Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
Kelderman, Sander
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O). [electronic resource] - Acta oncologica (Stockholm, Sweden) Nov 2013 - 1786-8 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1651-226X
10.3109/0284186X.2013.786839 doi
Adolescent
Antibodies, Monoclonal--therapeutic use
Follow-Up Studies
Humans
Immunotherapy
Ipilimumab
Melanoma--drug therapy
Neoplasm Staging
Netherlands
Prognosis
Retrospective Studies
Survival Rate
Uveal Neoplasms--drug therapy
Uveal Melanoma
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O). [electronic resource] - Acta oncologica (Stockholm, Sweden) Nov 2013 - 1786-8 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1651-226X
10.3109/0284186X.2013.786839 doi
Adolescent
Antibodies, Monoclonal--therapeutic use
Follow-Up Studies
Humans
Immunotherapy
Ipilimumab
Melanoma--drug therapy
Neoplasm Staging
Netherlands
Prognosis
Retrospective Studies
Survival Rate
Uveal Neoplasms--drug therapy
Uveal Melanoma